View printer-friendly version
« Back
June 12, 2013 4:06 p.m.
Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jun. 12, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes, CA. Dr. Jeremy M. Levin, President & CEO, will present on Thursday, June 13, 2013.

 

What:

Teva Presentation at the Goldman Sachs 34th Annual Global Healthcare Conference
 

Who:

Dr. Jeremy M. Levin, President & CEO, Teva Pharmaceutical Industries Ltd.
 

When:

Thursday, June 13, 2013 at 9:20 AM PT
 

Where:

www.tevapharm.com

 

How:

Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.
 

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.

Source: Teva Pharmaceutical Industries Ltd.